XAIRBeyond Air, Inc.

XAIR Stock Price, Valuation & Chart | Beyond Air, Inc.

Compare

$3.620-0.04 (-1.09%)

At close · 02 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Medical - Devices XAIR intrinsic value XAIR calculated fair value vs price

Overview Financials Dividends Ratios

XAIR Historical price chart

XAIR Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization2.61M

PE Ratio-0.08

EPS-48.1

Trading Volume139.56K

Today's High/Low3.95/3.61

Dividend Yield0.00

52 Week High/Low95.6/3.6

Shares Outstanding720.53K

XAIR Financial Statement

XAIR Analyst ratings

XAIR Analysis & performance metrics

XAIR Company profile

Beyond Air, Inc. operates as a commercial medical device and biopharmaceutical company. The company engages in the development of LungFit platform, a nitric oxide generator…

Beyond Air, Inc. operates as a commercial medical device and biopharmaceutical company. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment of viral lung infections, such as…

XAIR Management team

Name

Position

Steven Adam LisiCEO

Chief Executive Officer & Chairman of the Board

Andrew R. Colin M.D.CTO

Senior Medical Director Global Clinical Leadership & Member of Scientific Advisory Board

Michael A. GaulCOO

Chief Operating Officer

Adam Newman

Corporate Secretary

John Jett Ph.D.

Head of Research & Clinical Development

David R. Webster

Chief Commercial Officer

Amir AvnielCEO

Chief Executive Officer of NeuroNOS

Douglas Quinton LarsonCFO

Chief Financial Officer, Principal Financial Officer & Principal Accounting Officer

Name

Position

Steven Adam LisiCEO

Chief Executive Officer & Chairman of the Board

Andrew R. Colin M.D.CTO

Senior Medical Director Global Clinical Leadership & Member of Scientific Advisory Board

Michael A. GaulCOO

Chief Operating Officer

Adam Newman

Corporate Secretary

John Jett Ph.D.

Head of Research & Clinical Development

David R. Webster

Chief Commercial Officer

Amir AvnielCEO

Chief Executive Officer of NeuroNOS

Douglas Quinton LarsonCFO

Chief Financial Officer, Principal Financial Officer & Principal Accounting Officer

Management Team

Steven Adam LisiCEO

Chief Executive Officer & Chairman of the Board

Andrew R. Colin M.D.CTO

Senior Medical Director Global Clinical Leadership & Member of Scientific Advisory Board

Michael A. GaulCOO

Chief Operating Officer

Adam Newman

Corporate Secretary

John Jett Ph.D.

Head of Research & Clinical Development

David R. Webster

Chief Commercial Officer

Amir AvnielCEO

Chief Executive Officer of NeuroNOS

Douglas Quinton LarsonCFO

Chief Financial Officer, Principal Financial Officer & Principal Accounting Officer

Management

Steven Adam LisiCEO

Chief Executive Officer & Chairman of the Board

Andrew R. Colin M.D.CTO

Senior Medical Director Global Clinical Leadership & Member of Scientific Advisory Board

Michael A. GaulCOO

Chief Operating Officer

Adam Newman

Corporate Secretary

John Jett Ph.D.

Head of Research & Clinical Development

David R. Webster

Chief Commercial Officer

Amir AvnielCEO

Chief Executive Officer of NeuroNOS

Douglas Quinton LarsonCFO

Chief Financial Officer, Principal Financial Officer & Principal Accounting Officer

Total 8 executives

XAIR Frequently asked questions

What is Beyond Air, Inc. (XAIR) Stock Price?

Current stock price of Beyond Air, Inc. (XAIR) stock is $3.620. The stock price is -1.09% lower in the session. The intraday range can be seen from this page. Volume of Beyond Air, Inc. (XAIR) stock is 139.56K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Beyond Air, Inc. (XAIR) stock price going up or down today?

The stock price of Beyond Air, Inc. (XAIR) can change with earnings, company news, and overall market sentiment. Beyond Air, Inc. operates in the Healthcare / Medical - Devices market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Beyond Air, Inc. stock expensive at its current price?

Whether Beyond Air, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for XAIR on this page is -0.08. EPS on this page is -48.10. Compare those figures with peers and growth expectations before deciding if the current Beyond Air, Inc. price is justified.

How has the stock price of Beyond Air, Inc. (XAIR) performed historically?

Historical performance for Beyond Air, Inc. (XAIR) is shown on the price chart on this page. Review multi-period moves alongside volume to see how XAIR reacted to past earnings and market events.

Should I buy Beyond Air, Inc. (XAIR) stock, at this price?

Buying Beyond Air, Inc. (XAIR) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.